{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:08:07Z","timestamp":1783001287063,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurol.2025.07.009","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:21Z","timestamp":1762962201000},"page":"852-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lessons learned from 30 years of presymptomatic testing in Huntington Disease"],"prefix":"10.1016","volume":"181","author":[{"given":"L.","family":"Pierron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.07.009_bib0275","first-page":"572","volume":"171","author":"Cl\u00e9ment","year":"2015","journal-title":"Guidelines for presymptomatic testing for Huntington's disease: Past, present and future in France. Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2025.07.009_bib0280","article-title":"D\u00e9cret n\u00b0 2000-570 du 23 juin 2000 fixant les conditions de prescription et de r\u00e9alisation des examens des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne et de son identification par empreintes g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales et modifiant le code de la sant\u00e9","volume":"147","year":"2000","journal-title":"JORF"},{"key":"10.1016\/j.neurol.2025.07.009_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.009_bib0290","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/awab423","article-title":"Antisense therapies in neurological diseases","volume":"145","author":"Brunet De Courssou","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.009_bib0295","first-page":"104","article-title":"Effect of Triheptanoin on caudate atrophy and motor scores in patients with early-stage Huntington disease: a phase II study","author":"Mochel","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.009_bib0300","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1474-4422(25)00071-7","article-title":"Uncontrolled CAG expansion in neurons susceptible to Huntington's disease","volume":"24","author":"Durr","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.009_bib0305","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington's disease","volume":"29","author":"Gusella","year":"2014","journal-title":"Movet Dis"},{"key":"10.1016\/j.neurol.2025.07.009_bib0310","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2025.07.009_bib0315","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2025.07.009_bib0320","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2025.07.009_bib0325","series-title":"Huntington's disease in a historical context. vol. 1","author":"Harper","year":"2014"},{"key":"10.1016\/j.neurol.2025.07.009_bib0330","first-page":"555","article-title":"Clinical practice in medical genetics Guidelines for the molecular genetics predictive test in Huntington's disease","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-510X(89)90243-8","article-title":"WFN research committee: research group on Huntington's Chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test","volume":"94","author":"Sciences","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2025.07.009_bib0340","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","article-title":"Recommendations for the predictive genetic test in Huntington's disease","volume":"83","author":"Macleod","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0345","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/01.WNL.0000032255.75650.C2","article-title":"Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias","volume":"59","author":"Goizet","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.009_bib0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ejhg.2009.25","article-title":"Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations","volume":"17","author":"Borry","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0355","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","article-title":"22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium","volume":"24","author":"Baig","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0360","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-0004.2010.01603.x","article-title":"Huntington's disease in Greece: the experience of 14 years","volume":"80","author":"Panas","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","article-title":"Uptake of Huntington disease predictive testing in a complete population","volume":"80","author":"Morrison","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0370","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S1415-47572014000200012","article-title":"Genetic counseling and presymptomatic testing programs for Machado-Joseph disease: Lessons from Brazil and Portugal","volume":"37","author":"Schuler-Faccini","year":"2014","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.neurol.2025.07.009_bib0375","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cge.12142","article-title":"The Cuban program for predictive testing of SCA2: 11years and 768 individuals to learn from","volume":"83","author":"Cruz-Mari\u00f1o","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0380","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/21678421.2017.1332079","article-title":"Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations","volume":"18","author":"Crook","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.009_bib0385","first-page":"7","article-title":"Who and why? Requests for presymptomatic genetic testing for amyotrophic lateral sclerosis\/Frontotemporal dementia vs Huntington Disease","author":"Amador","year":"2021","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0390","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41431-020-00776-8","article-title":"Informing about genetic risk in families with Huntington disease: comparison of attitudes across two decades","volume":"29","author":"Pierron","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0395","article-title":"D\u00e9cret n\u00b0 2013-527 du 20 juin 2013 relatif aux conditions de mise en \u0153uvre de l\u2019information de la parent\u00e8le dans le cadre d\u2019un examen des caract\u00e9ristiques g\u00e9n\u00e9tiques \u00e0 finalit\u00e9 m\u00e9dicale","volume":"0143","year":"2013","journal-title":"JORF"},{"key":"10.1016\/j.neurol.2025.07.009_bib0400","series-title":"Vivre avec une maladie g\u00e9n\u00e9tique","author":"Gargiulo","year":"2009"},{"key":"10.1016\/j.neurol.2025.07.009_bib0405","first-page":"21","article-title":"Tests g\u00e9n\u00e9tiques et m\u00e9decine pr\u00e9dictive\u00a0: quels enjeux\u00a0?","volume":"68","author":"H\u00e9ron","year":"2009","journal-title":"Sante Med Ethique"},{"key":"10.1016\/j.neurol.2025.07.009_bib0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ejhg.2008.146","article-title":"Long-term outcome of presymptomatic testing in Huntington disease","volume":"17","author":"Gargiulo","year":"2009","journal-title":"Eur J Hum"},{"key":"10.1016\/j.neurol.2025.07.009_bib0415","series-title":"Le conseil g\u00e9n\u00e9tique","author":"Bordet","year":"2018"},{"key":"10.1016\/j.neurol.2025.07.009_bib0420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08989621.2011.575033","article-title":"A clinical perspective on ethical issues in genetic testing","volume":"18","author":"Sijmons","year":"2011","journal-title":"Account Res"},{"key":"10.1016\/j.neurol.2025.07.009_bib0425","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3917\/espri.1407.0052","article-title":"Anticiper le handicap. Les risques psychologiques des tests g\u00e9n\u00e9tiques","author":"Gargiulo","year":"2014","journal-title":"Esprit"},{"key":"10.1016\/j.neurol.2025.07.009_bib0430","first-page":"83","article-title":"Enjeux de la m\u00e9decine pr\u00e9dictive en neurog\u00e9n\u00e9tique\u00a0: quelle place pour l\u2019homme\u00a0?","volume":"55","author":"D\u00fcrr","year":"2009","journal-title":"Champ Psychosomatique"},{"key":"10.1016\/j.neurol.2025.07.009_bib0435","series-title":"The Rites of Passage. Second Edition","author":"van Gennep","year":"2019"},{"key":"10.1016\/j.neurol.2025.07.009_bib0440","first-page":"428","article-title":"Le ph\u00e9nom\u00e8ne rituel. Structure & contre-structure","volume":"44","author":"Van Canneghem","year":"1991","journal-title":"Bull Psychol"},{"key":"10.1016\/j.neurol.2025.07.009_bib0445","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jmedgenet-2016-104199","article-title":"A liminal stage after predictive testing for Huntington disease","volume":"54","author":"Gargiulo","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3917\/eres.hirsc.2018.01.0237","article-title":"Liminalit\u00e9 apr\u00e8s un diagnostic g\u00e9n\u00e9tique pr\u00e9symptomatique","author":"Gargiulo","year":"2018","journal-title":"Trait\u00e9 de Bio\u00e9thique"},{"key":"10.1016\/j.neurol.2025.07.009_bib0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3917\/ado.072.0443","article-title":"Strat\u00e9gies d\u2019immortalit\u00e9","volume":"28","author":"Triandafillidis","year":"2010","journal-title":"Adolescence"},{"key":"10.1016\/j.neurol.2025.07.009_bib0460","series-title":"La pr\u00e9diction d\u2019une maladie et d\u2019un handicap. Handicap et mort","first-page":"13","article-title":"\u00ab\u00a0C\u2019est arriv\u00e9 demain\u00a0\u00bb","author":"Gargiulo","year":"2019"},{"key":"10.1016\/j.neurol.2025.07.009_bib0465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0738-3991(98)00086-X","article-title":"Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals","volume":"35","author":"Evers-Kiebooms","year":"1998","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.neurol.2025.07.009_bib0470","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrg.2016.97","article-title":"Prenatal and pre-implantation genetic diagnosis","volume":"17","author":"Vermeesch","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0475","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/ejhg.2016.59","article-title":"Prenatal testing in Huntington disease: after the test, choices recommence","volume":"24","author":"Bouchghoul","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0480","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41436-018-0367-z","article-title":"27 years of prenatal diagnosis for Huntington disease in the United Kingdom","volume":"21","author":"Pi\u00f1a-Aguilar","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.neurol.2025.07.009_bib0485","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cge.12090","article-title":"Prenatal testing for Huntington's disease in the Netherlands from 1998 to 2008","volume":"85","author":"van Rij","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0490","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.ejhg.5201774","article-title":"The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation","volume":"15","author":"Decruyenaere","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0495","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jmg-2022-108477","article-title":"Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severities","volume":"60","author":"Pierron","year":"2023","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2025.07.009_bib0500","first-page":"94","article-title":"Le choix du diagnostic pr\u00e9implantatoire: un attracteur de l\u2019ambivalence du d\u00e9sir d\u2019enfant dans les maladies g\u00e9n\u00e9tiques \u00e0 r\u00e9v\u00e9lation tardive","volume":"84","author":"Staraci","year":"2017","journal-title":"Spirale"},{"key":"10.1016\/j.neurol.2025.07.009_bib0505","series-title":"\u00c9thique et Famille, vol. 2","first-page":"143","article-title":"\u00ab\u00a0Que dois-je transmettre \u00e0 mes enfants\u00a0?\u00a0\u00bb Gravit\u00e9 des maladies h\u00e9r\u00e9ditaires et choix procr\u00e9atifs","author":"Dekeuwer","year":"2011"},{"key":"10.1016\/j.neurol.2025.07.009_bib0510","first-page":"267","article-title":"Prise de d\u00e9cision dans le centre pluridisciplinaire de diagnostic pr\u00e9natal: le changement est permis","volume":"20","author":"Missonnier","year":"2023","journal-title":"Ethique Sante"},{"key":"10.1016\/j.neurol.2025.07.009_bib0515","first-page":"787","article-title":"Huntington's disease alters human neurodevelopment","volume":"369","author":"Barnat","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.neurol.2025.07.009_bib0520","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurol.2024.04.001","article-title":"A developmental component to Huntington's disease","volume":"180","author":"Rati\u00e9","year":"2024","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2025.07.009_bib0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.009_bib0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study","volume":"6","author":"Paulsen","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurol.2025.07.009_bib0535","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/mds.26364","article-title":"Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD","volume":"30","author":"Long","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2025.07.009_bib0540","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872500582X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872500582X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:36:42Z","timestamp":1763177802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537872500582X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S003537872500582X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.07.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned from 30 years of presymptomatic testing in Huntington Disease","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}